Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Suspended 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 522 Neoplasms 470 Carcinoma, Non-Small-Cell Lung 393 Prostatic Neoplasms 302 Colorectal Neoplasms 296 Lung Neoplasms 259 Neoplasm Metastasis 217 Ovarian Neoplasms 198 Leukemia, Myeloid, Acute 194 Pancreatic Neoplasms 185 Multiple Myeloma 172 Squamous Cell Carcinoma of Head and Neck 133 Recurrence 132 Stomach Neoplasms 129 Brain Neoplasms 126 Melanoma 123 Carcinoma, Hepatocellular 123 Endometrial Neoplasms 120 Glioblastoma 118 Triple Negative Breast Neoplasms 111 Precursor Cell Lymphoblastic Leukemia-Lymphoma 105 Hematologic Neoplasms 99 Head and Neck Neoplasms 97 Carcinoma, Renal Cell 96 Lymphoma 93 Urinary Bladder Neoplasms 90 Sarcoma 90 Glioma 88 Lymphoma, Large B-Cell, Diffuse 81 Small Cell Lung Carcinoma 80

Interventions

Testosterone 1 Gels 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hypogonadism × 90 days × Clear all

NCT04301765 2026-03-31

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting

Eunuchism, Fatigue, Hypogonadism, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡